These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of Brain Metastases in the New Era of Checkpoint Inhibition. Lauko A; Thapa B; Venur VA; Ahluwalia MS Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715 [TBL] [Abstract][Full Text] [Related]
3. Targeted and immunotherapeutic approaches in brain metastases. Ahluwalia MS; Winkler F Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144 [TBL] [Abstract][Full Text] [Related]
4. Targeted Therapies for Brain Metastases from Breast Cancer. Venur VA; Leone JP Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649142 [TBL] [Abstract][Full Text] [Related]
5. Management of brain metastases in patients with melanoma. Tarhini AA; Agarwala SS Curr Opin Oncol; 2004 Mar; 16(2):161-6. PubMed ID: 15075910 [TBL] [Abstract][Full Text] [Related]
6. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962 [TBL] [Abstract][Full Text] [Related]
8. Melanoma brain metastases: an unmet challenge in the era of active therapy. Gorantla V; Kirkwood JM; Tawbi HA Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973 [TBL] [Abstract][Full Text] [Related]
10. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049 [TBL] [Abstract][Full Text] [Related]
11. Systemic therapies for melanoma brain metastases: which drug for whom and when? Ramanujam S; Schadendorf D; Long GV Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811 [TBL] [Abstract][Full Text] [Related]
12. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases. Ramakrishna R; Formenti S World Neurosurg; 2019 Oct; 130():615-622. PubMed ID: 31581411 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment. Zhang I; Formenti SC; Knisely JPS Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951 [TBL] [Abstract][Full Text] [Related]
15. Management of brain metastases according to molecular subtypes. Soffietti R; Ahluwalia M; Lin N; Rudà R Nat Rev Neurol; 2020 Oct; 16(10):557-574. PubMed ID: 32873927 [TBL] [Abstract][Full Text] [Related]
19. Brain metastases: radiosurgery. Wolf A; Kondziolka D Handb Clin Neurol; 2018; 149():129-135. PubMed ID: 29307350 [TBL] [Abstract][Full Text] [Related]
20. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy. Sekine A; Satoh H Med Oncol; 2017 Jul; 34(7):121. PubMed ID: 28555261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]